SWP
BLUE

Stratos Wealth Partners’s bluebird bio BLUE Stock Holding History

Stratos Wealth Partners’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-352
Closed -$278K – 1021
2020
Q2 		$278K Buy
+352
New +$265K 0.01% 797
2018
Q4 		– Sell
-56
Closed -$106K – 1002
2018
Q3 		$106K Buy
+56
New +$116K ﹤0.01% 1095
2018
Q2 		– Sell
-58
Closed -$128K – 1144
2018
Q1 		$128K Buy
58
+9
+18% +$22.9K 0.01% 1070
2017
Q4 		$112K Buy
+49
New +$99.5K 0.01% 1125

Other funds holding BLUE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Stratos Wealth Partners's BLUE Position: Q3 2020 in Review

Stratos Wealth Partners sold out of bluebird bio (BLUE) in Q3 2020, closing a stake of 352 shares — an estimated $278K sold.

Stratos Wealth Partners first reported a position in BLUE in Q4 2017 and held it in 4 quarters. The position peaked at $278K in Q2 2020. 275 funds tracked by Wall St. Rank hold BLUE as of Q3 2020.

  • Stratos Wealth Partners reported no remaining bluebird bio position as of Q3 2020 after selling out during the quarter.
  • Stratos Wealth Partners sold 352 bluebird bio shares in Q3 2020, an estimated $278K.
  • Stratos Wealth Partners first reported a position in bluebird bio in Q4 2017 and held it in 4 quarters.
  • Stratos Wealth Partners's bluebird bio position peaked at $278K in Q2 2020.
  • 275 funds tracked by Wall St. Rank held bluebird bio as of Q3 2020.

Based on Stratos Wealth Partners's 13F filing for Q3 2020, filed 29 Oct 2020.